Sfoglia per Autore
Neo-adjuvant chemotherapy prior to surgery in stage III non-small cell lung cancer.
1997-01-01 SCAGLIOTTI GV; FERRARI G; S. NOVELLO
Carcinoma polmonare non a piccole cellule.
1998-01-01 S. NOVELLO; SCAGLIOTTI GV
New drugs for new chemotherapy standards.
1999-01-01 SCAGLIOTTI GV; S. NOVELLO
Multidrug resistance in non-small cell lung cancer.
1999-01-01 SCAGLIOTTI GV; NOVELLO S, SELVAGGI G
PHASE I/II DOSE FINDING STUDY OF PACLITAXEL AND CARBOPLATIN IN ADVANCED NON-SMALL CELL LUNG CANCER.
1999-01-01 SCAGLIOTTI GV; CRINÒ L; POZZI E; CORGNA E; SELVAGGI G; S. NOVELLO; SALSANO G; GENTILE A; PALLADINO M; MARRACOLO F; TONATO M
Gemcitabine as second-line treatment for advanced Non-Small cell lung cancer; a phase II trial.
1999-01-01 CRINÒ L; MOSCONI AM; SCAGLIOTTI G; SELVAGGI G; S. NOVELLO; RINALDI M; DELLA GIULIA M; GRIDELLI C; ROSSI A; CALANDRI C; DE MARINIS F; NOSEDA M; TONATO M
European perspectives on taxol/platinum-based therapy for advanced non-small cell lung cancer.
2000-01-01 T LE CHEVALIER; S. NOVELLO
A three-week schedule of gemcitabine-cisplatin in advanced non-small cell lung cancer with two different cisplatin dose levels: a phase II randomised trial.
2000-01-01 RINALDI M; CRINÒ L; SCAGLIOTTI GV; MOSCONI AM; DEMARINIS F; GRIDELLI C; SELVAGGI G; DELLA GIULIA M; DARWISH S; PORROZZI S; S. NOVELLO; CIPRI A; BARTOLUCCI R; CALANDRI C; TONATO M
IS THERE A STANDARD STRATEGY IN THE MANAGEMENT OF LOCALLY ADVANCED NSCLC?
2001-01-01 S. NOVELLO; T. LE CHEVALIER
BASI GENETICHE E BIOLOGIA MOLECOLARE
2001-01-01 SCAGLIOTTI GV; NOVELLO S
EUROPEAN PERSPECTIVES ON PACLITAXEL/PLATINUM-BASED THERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER.
2001-01-01 S. NOVELLO; LE CHEVALIER T
ACTIVITY AND TOXICITY OF GEMCITABINE AND GEMCITABINEVINORELBINE IN ADVANCED NON SMALL CELL LUNG CANCER ELDERLY PATIENTS. PHASE II DATA FROM THE MULTICENTER ITALIAN LUNG CANCER IN THE ELDERLY STUDY MILES RANDOMISED TRIAL.
2001-01-01 GRIDELLI C; CIGOLARI S; GALLO C; MANZIONE L; IANNELLO GP; FRONTINI L; FERRAÙ F; S. NOVELLO; PERRONE F; ON BEHALF OF THE MILES INVESTIGATORS
Ongoing/planned studies in France stage I-II NSCLC.
2001-01-01 S. NOVELLO; T LE CHEVALIER
Neoplasie Polmonari.
2001-01-01 SCAGLIOTTI GV; SELVAGGI G; S. NOVELLO
ALIMTA (PEMETREXED DISODIUM, LY231514, MTA): CLINICAL EXPERIENCE IN NON-SMALL CELL LUNG CANCER (NSCLC).
2001-01-01 S. NOVELLO; T. LE CHEVALIER
PHASE II STUDY OF HIGH-DOSE PACLITAXEL AND CARBOPLATIN IN PREVIOUSLY UNTREATED, URESECTABLE NON-SMALL CELL LUNG CANCER.
2001-01-01 S. NOVELLO; GALLI L; ANTONUZZO A; CRINÓ L; POZZI E; SELVAGGI G; RICCI S; MARROCOLO F; DARWISH S; SORBOLINI S; TONATO M, SCAGLIOTTI GV
ROLE OF ERYTHROPOIETIN IN THE TREATMENT OF LUNG CANCER ASSOCIATED ANEMIA.
2001-01-01 GV SCAGLIOTTI; S. NOVELLO
Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancer
2001-01-01 Novello, S; Galli, L; Antonuzzo, A; Crinó, L; Pozzi, E; Selvaggi, G; Ricci, S; Marrocolo, F; Darwish, S; Sorbolini, S; Tonato, M; Scagliotti, GV
HER-2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma. Impact on long-term survival.
2002-01-01 Selvaggi G; Scagliotti GV; Torri V; Novello S; Leonardo E; Cappia S; Mossetti C; Ardissone F; Lausi P; Borasio P.
HER-2/NEU OVEREXPRESSION IN PATIENTS WITH RADICALLY RESECTED NONSMALL CELL LUNG CARCINOMA. IMPACT ON LONG-TERM SURVIVAL.
2002-01-01 SELVAGGI G; SCAGLIOTTI GV; TORRI V; S. NOVELLO; LEONARDO E; CAPPIA S; MOSSETTI C; ARDISSONE F; LAUSI P; BORASIO P
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile